173 related articles for article (PubMed ID: 37033868)
1. Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine.
Vignaux PA; Lane TR; Puhl AC; Hau RK; Wright SH; Cherrington NJ; Ekins S
ACS Omega; 2023 Apr; 8(13):12532-12537. PubMed ID: 37033868
[TBL] [Abstract][Full Text] [Related]
2. Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters.
Martinez-Guerrero L; Zhang X; Zorn KM; Ekins S; Wright SH
J Pharmacol Exp Ther; 2021 Oct; 379(1):96-107. PubMed ID: 34253645
[TBL] [Abstract][Full Text] [Related]
3. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine:
Puhl AC; Fritch EJ; Lane TR; Tse LV; Yount BL; Sacramento CQ; Fintelman-Rodrigues N; Tavella TA; Maranhão Costa FT; Weston S; Logue J; Frieman M; Premkumar L; Pearce KH; Hurst BL; Andrade CH; Levi JA; Johnson NJ; Kisthardt SC; Scholle F; Souza TML; Moorman NJ; Baric RS; Madrid PB; Ekins S
ACS Omega; 2021 Mar; 6(11):7454-7468. PubMed ID: 33778258
[TBL] [Abstract][Full Text] [Related]
4. The interactions of lenalidomide with human uptake and efflux transporters and UDP-glucuronosyltransferase 1A1: lack of potential for drug-drug interactions.
Tong Z; Yerramilli U; Surapaneni S; Kumar G
Cancer Chemother Pharmacol; 2014 Apr; 73(4):869-74. PubMed ID: 24627218
[TBL] [Abstract][Full Text] [Related]
5. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
[TBL] [Abstract][Full Text] [Related]
6. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro.
Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540
[TBL] [Abstract][Full Text] [Related]
7. In vitro assessment of the roles of drug transporters in the disposition and drug-drug interaction potential of olaparib.
McCormick A; Swaisland H
Xenobiotica; 2017 Oct; 47(10):903-915. PubMed ID: 27684210
[TBL] [Abstract][Full Text] [Related]
8. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
[TBL] [Abstract][Full Text] [Related]
9. Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Rizk ML; Houle R; Chan GH; Hafey M; Rhee EG; Chu X
Antimicrob Agents Chemother; 2014; 58(3):1294-301. PubMed ID: 24295974
[TBL] [Abstract][Full Text] [Related]
10. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
[TBL] [Abstract][Full Text] [Related]
11. Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms.
Puhl AC; Fritch EJ; Lane TR; Tse LV; Yount BL; Sacramento CQ; Tavella TA; Costa FTM; Weston S; Logue J; Frieman M; Premkumar L; Pearce KH; Hurst BL; Andrade CH; Levi JA; Johnson NJ; Kisthardt SC; Scholle F; Souza TML; Moorman NJ; Baric RS; Madrid P; Ekins S
bioRxiv; 2020 Dec; ():. PubMed ID: 33299990
[TBL] [Abstract][Full Text] [Related]
12. Toward the Target: Tilorone, Quinacrine, and Pyronaridine Bind to Ebola Virus Glycoprotein.
Lane TR; Ekins S
ACS Med Chem Lett; 2020 Aug; 11(8):1653-1658. PubMed ID: 32832035
[TBL] [Abstract][Full Text] [Related]
13. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins.
Neul C; Hofmann U; Schaeffeler E; Winter S; Klein K; Giacomini KM; Eichelbaum M; Schwab M; Nies AT
Br J Pharmacol; 2021 Mar; 178(6):1459-1474. PubMed ID: 33434947
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
16. Interactions of bilastine, a new oral H₁ antihistamine, with human transporter systems.
Lucero ML; Gonzalo A; Ganza A; Leal N; Soengas I; Ioja E; Gedey S; Jahic M; Bednarczyk D
Drug Chem Toxicol; 2012 Jun; 35 Suppl 1():8-17. PubMed ID: 22616811
[TBL] [Abstract][Full Text] [Related]
17. Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K.
Xiao G; Rowbottom C; Boiselle C; Gan LS
Pharm Res; 2018 Jun; 35(8):159. PubMed ID: 29915999
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Drug-Drug Interactions of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor, With Transporter Substrates Based on In Vitro and Clinical Studies.
Shimizu R; Matsuzaki T; Oka R; Sonoyama T; Fukuhara T; Kuwata A; Matsuo Y; Kubota R
J Clin Pharmacol; 2023 Aug; 63(8):918-927. PubMed ID: 37043676
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
Lane TR; Dyall J; Mercer L; Goodin C; Foil DH; Zhou H; Postnikova E; Liang JY; Holbrook MR; Madrid PB; Ekins S
Antiviral Res; 2020 Oct; 182():104908. PubMed ID: 32798602
[TBL] [Abstract][Full Text] [Related]
20. Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition.
Hanna I; Alexander N; Crouthamel MH; Davis J; Natrillo A; Tran P; Vapurcuyan A; Zhu B
Xenobiotica; 2018 Mar; 48(3):300-313. PubMed ID: 28281384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
